Skip to main content

Decision Aid

0
Pipeline Programs
5
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

MSD
MSDIreland - Ballydine
1 program
Patient decision aidN/A1 trial
Active Trials
NCT06435338Completed632Est. Jan 2024
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
Patient decision aidN/A
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
Patient decision aidN/A
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
1 program
Patient decision aidN/A
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Visual ArrayN/A1 trial
Active Trials
NCT06994832Completed1,045Est. Aug 2025

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Human BioSciencesVisual Array
MSDPatient decision aid

Clinical Trials (2)

Total enrollment: 1,677 patients across 2 trials

Using Visual Arrays to Support Understanding of Genetic Risk

Start: Jul 2025Est. completion: Aug 20251,045 patients
N/ACompleted
NCT06435338MSDPatient decision aid

Patient Decision Aid Tool for HPV Vaccination Among Adults Ages 27-45 Years Old

Start: Dec 2023Est. completion: Jan 2024632 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.